Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Clinical trial NCT02792725 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT02792725
- Sponsor
- Eli Lilly and Company
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.